| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment
|
Kuo, Cheng-Liang
|
|
|
72 |
2 |
p. 351-369
|
artikel
|
| 2 |
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer
|
Chen, Jiannan
|
|
|
72 |
2 |
p. 409-425
|
artikel
|
| 3 |
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
|
An, Mengchao
|
|
|
72 |
2 |
p. 385-395
|
artikel
|
| 4 |
Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors
|
Sasatani, Yuika
|
|
|
72 |
2 |
p. 523-525
|
artikel
|
| 5 |
CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?
|
Ganapathy, Thamizhselvi
|
|
|
72 |
2 |
p. 277-286
|
artikel
|
| 6 |
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
|
Wang, Jie
|
|
|
72 |
2 |
p. 493-507
|
artikel
|
| 7 |
Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer
|
Gao, Yinjie
|
|
|
72 |
2 |
p. 339-350
|
artikel
|
| 8 |
Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma
|
Zhang, Xin-Wen
|
|
|
72 |
2 |
p. 509-513
|
artikel
|
| 9 |
Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma
|
Jeon, Seung Hyuck
|
|
|
72 |
2 |
p. 371-384
|
artikel
|
| 10 |
High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in advanced colorectal cancer
|
Hexun, Zhang
|
|
|
72 |
2 |
p. 315-326
|
artikel
|
| 11 |
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
|
Feng, Yu
|
|
|
72 |
2 |
p. 449-459
|
artikel
|
| 12 |
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma
|
Ballhausen, Alexej
|
|
|
72 |
2 |
p. 515-521
|
artikel
|
| 13 |
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
|
Ikoma, Tatsuki
|
|
|
72 |
2 |
p. 427-435
|
artikel
|
| 14 |
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma
|
Yan, Haimeng
|
|
|
72 |
2 |
p. 327-338
|
artikel
|
| 15 |
Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients
|
Yuan, Shumin
|
|
|
72 |
2 |
p. 437-448
|
artikel
|
| 16 |
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
|
De Jaeghere, Emiel A.
|
|
|
72 |
2 |
p. 475-491
|
artikel
|
| 17 |
Personalized tumor vaccine for pancreatic cancer
|
Orr, Shira
|
|
|
72 |
2 |
p. 301-313
|
artikel
|
| 18 |
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
|
Cho, Helen
|
|
|
72 |
2 |
p. 287-300
|
artikel
|
| 19 |
Single-cell analysis of peripheral CD8+ T cell responses in patients receiving checkpoint blockade immunotherapy for cancer
|
Khojandi, Niloufar
|
|
|
72 |
2 |
p. 397-408
|
artikel
|
| 20 |
Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma
|
Lauridsen, Kasper Munch
|
|
|
72 |
2 |
p. 461-473
|
artikel
|
Tijdschrift beschrijving